Zobrazeno 1 - 10
of 867
pro vyhledávání: '"Gibofsky A"'
Autor:
Alain Saraux, Licia Maria Henrique da Mota, Sanjay Dixit, Allan Gibofsky, Tsukasa Matsubara, Amy Mulvey, Cheryl Koehn, Mahta Mortezavi, Michelle Segovia, Meriem Kessouri
Publikováno v:
Rheumatology and Therapy, Vol 11, Iss 2, Pp 257-268 (2024)
Abstract Introduction The global coronavirus 2019 (COVID-19) pandemic created many challenges in healthcare provision. This study aimed to evaluate the global impact of the COVID-19 pandemic on people living with rheumatoid arthritis (RA). Methods Th
Externí odkaz:
https://doaj.org/article/aa7976799db9487fa5130b2db5dae492
Autor:
Yazici, Y. †, ‡, McAlindon, T.E. §, Gibofsky, A. ‖, Lane, N.E. ¶, Lattermann, C. #, Skrepnik, N. ††, Swearingen, C.J. †, Simsek, I. †, Ghandehari, H. †, DiFrancesco, A. †, Gibbs, J. †, Tambiah, J.R.S. †, Hochberg, M.C. ‡‡
Publikováno v:
In Osteoarthritis and Cartilage May 2021 29(5):654-666
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Allan Gibofsky, Gary Jacobson, Archie Franklin, Shannan O’Hara-Levi, Laurent Peyrin-Biroulet, Melissa McGrath, Dorothy McCabe
Publikováno v:
Journal of Managed Care & Specialty Pharmacy. 29:343-349
Autor:
Anne R Bass, Bella Mehta, Mark Alan Fontana, Susan M Goodman, Deanna Jannat-Khah, Carine J Moezinia, Carol A Mancuso, Vinicius C Antao, Allan Gibofsky, Said Ibrahim
Publikováno v:
RMD Open, Vol 6, Iss 3 (2020)
Objective There is emerging evidence that COVID-19 disproportionately affects people from racial/ethnic minority and low socioeconomic status (SES) groups. Many physicians across the globe are changing practice patterns in response to the COVID-19 pa
Externí odkaz:
https://doaj.org/article/2ed40180f7ac4c0d92519ee0a4c014fd
Autor:
Allan Gibofsky, James Galloway, Joern Kekow, Cristiano Zerbini, Maria de la Vega, Gavin Lee, Eun Young Lee, Catalin Codreanu, Cheryl Koehn, Kathy Steinberg, Eustratios Bananis, Dario Ponce de Leon, Anna Maniccia, Ara Dikranian, for the RA NarRAtive global advisory panel
Publikováno v:
Health and Quality of Life Outcomes, Vol 16, Iss 1, Pp 1-11 (2018)
Abstract Background In order to better understand the perspectives of patients and physicians regarding the treatment and management of rheumatoid arthritis (RA), we present and compare results from a patient-based and a physician-based survey develo
Externí odkaz:
https://doaj.org/article/0e3ee8c712b14bdb969d0405849ce455
Autor:
Yazici, Y. †, McAlindon, T.E. ‡, Fleischmann, R. §, Gibofsky, A. ‖, Lane, N.E. ¶, Kivitz, A.J. #, Skrepnik, N. ††, Armas, E. ‡‡, Swearingen, C.J. †, DiFrancesco, A. †, Tambiah, J.R.S. †, Hood, J. †, Hochberg, M.C. §§
Publikováno v:
In Osteoarthritis and Cartilage October 2017 25(10):1598-1606
Autor:
Sophie Shubow, Qin Sun, Ai Len Nguyen Phan, Dana C. Hammell, Maureen Kane, Gary H. Lyman, Allan Gibofsky, Gary R. Lichtenstein, Zachary Bloomgarden, Raymond K. Cross, Sarah Yim, James E. Polli, Yow‐Ming Wang
Publikováno v:
Clinical Pharmacology & Therapeutics. 113:37-49
The approval and adoption of biosimilar products are essential to contain increasing healthcare costs and provide more affordable choices for patients. Despite steady progress in the number of the US Food and Drug Administration (FDA) biosimilar appr
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
The American journal of managed care. 28
Beyond the legal and regulatory limitations associated with biosimilar availability in the United States, the adoption of biosimilars is contingent on the willingness of health care providers (HCPs) to prescribe them and of patients to accept them. I